Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Automatic Data Processing Inc (ADP) vs DexCom, Inc. (DXCM) Price & Performance

Automatic Data Processing IncTrade
DexCom, Inc.Trade

Price performance (Past 24H)

Key statistics

Automatic Data Processing Inc vs DexCom, Inc. — how do they compare? Automatic Data Processing Inc trades at $267.32 (market cap $107.69B), while DexCom, Inc. trades at $90.36 (market cap $33.79B). The key difference: Automatic Data Processing Inc is far larger — about 3.2× DexCom, Inc.'s market cap, and Automatic Data Processing Inc pays a 2.51% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.

ADPDXCM
Market Cap
$107.69B$33.79B
Sector
IndustrialsHealth
52-Week High
$309.03$89.53
52-Week Low
$188.79$54.84
Enterprise Value
$108.73B$33.24B
Dividend Yield
2.51%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Automatic Data Processing Inc

ADP trades at $268.23, down 1.99% over the past day, with a bullish technical signal from moving averages and a consensus analyst price target of $280.50. The company reported strong earnings beats in recent quarters, with Q4 2026 EPS of $2.62 beating expectations, and maintains robust profitability with a net income margin of 20.11%. Recent news highlights dividend declarations and positive earnings momentum, though valuation ratios like a P/E of 24.78 suggest a premium.

The outlook for ADP is supported by consistent earnings growth and solid cash flow, but high valuation multiples and competitive pressures in payroll processing pose risks. Upside potential exists if the company meets Q3 2026 EPS expectations of $2.78, while macroeconomic labor market trends could impact performance. Analyst sentiment is mixed, with 63.89% holding, indicating cautious optimism amid elevated pricing.

DexCom, Inc.

DXCM trades at $90.23, up 2.94% today and near its 52-week high, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating EPS estimates with $0.70 versus $0.61 expected, and raised full-year guidance. Revenue growth remains robust at 13% year-over-year, supported by G7 system adoption and international expansion. Profit margins improved, with net income margin reaching 20.12% in 2025. Analyst sentiment is overwhelmingly positive, with 80% buy ratings.

The outlook for DXCM is favorable due to sustained demand for continuous glucose monitors and strategic initiatives like 'Road to 100'. Key risks include competitive pressures, regulatory scrutiny, and valuation multiples above industry averages. The stock's current price is slightly above the consensus target of $88.65, suggesting near-term consolidation may occur before further upside.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Automatic Data Processing Inc

ADP is a provider of payroll and human capital management solutions servicing the full scope of businesses from micro to global enterprises. ADP was established in 1949 and serves over 990,000 clients primarily in the United States. ADP's employer services segment offers payroll, HCM solutions, HR outsourcing, insurance and retirement services. The smaller but faster-growing PEO segment provides HR outsourcing solutions to small and midsize businesses through a co-employment model.

Read more on ADP

About DexCom, Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.

Read more on DXCM